Cargando…
Next generation self-replicating RNA vectors for vaccines and immunotherapies
RNA technology has recently come to the forefront of innovative medicines and is being explored for a wide range of therapies, including prophylactic and therapeutic vaccines, biotherapeutic protein expression and gene therapy. In addition to conventional mRNA platforms now approved for prophylactic...
Autores principales: | Aliahmad, Parinaz, Miyake-Stoner, Shigeki J., Geall, Andrew J., Wang, Nathaniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861484/ https://www.ncbi.nlm.nih.gov/pubmed/35194198 http://dx.doi.org/10.1038/s41417-022-00435-8 |
Ejemplares similares
-
An Update on Self-Amplifying mRNA Vaccine Development
por: Blakney, Anna K., et al.
Publicado: (2021) -
Next Generation Natural Killer Cells for Cancer Immunotherapy
por: Rossi, Fiorella, et al.
Publicado: (2022) -
Plant Viruses as Adjuvants for Next-Generation Vaccines and Immunotherapy
por: Nikitin, Nikolai, et al.
Publicado: (2023) -
Development of all CD4 T lineages requires nuclear factor TOX
por: Aliahmad, Parinaz, et al.
Publicado: (2008) -
Allergen hybrids – next generation vaccines for Fagales pollen immunotherapy
por: Pichler, U, et al.
Publicado: (2013)